N#N.CS(O[CH2:8][CH:9]([OH:39])[C:10]([NH:12][C:13]1[CH:18]=[CH:17][CH:16]=[C:15]([NH:19][C:20]2[C:25]([F:26])=[CH:24][N:23]=[C:22]([NH:27][C:28]3[CH:33]=[CH:32][C:31]([O:34][CH2:35][CH2:36][O:37][CH3:38])=[CH:30][CH:29]=3)[N:21]=2)[CH:14]=1)=[O:11])(=O)=O.C1COCC1.[H-].[Na+]>C(OCC)(=O)C.O.CCCCCC.C(OCC)(=O)C>[F:26][C:25]1[C:20]([NH:19][C:15]2[CH:14]=[C:13]([NH:12][C:10]([CH:9]3[CH2:8][O:39]3)=[O:11])[CH:18]=[CH:17][CH:16]=2)=[N:21][C:22]([NH:27][C:28]2[CH:29]=[CH:30][C:31]([O:34][CH2:35][CH2:36][O:37][CH3:38])=[CH:32][CH:33]=2)=[N:23][CH:24]=1Into a 25 mL 3-neck RBF equipped with N2-bubbler and thermo pocket was charged 3-((3-((5-fluoro-2-((4-(2-methoxyethoxy)phenyl)amino)pyrimidin-4-yl)amino)phenyl)amino)-2-hydroxy-3-oxopropyl methanesulfonate (0.03 g) and THF (2.0 mL). The reaction mixture was cooled to 0° C. and NaH (2.2 mg) was added. The reaction mixture was warmed to room temperature and stirred for 45 min. Completion of reaction was monitored on TLC using hexane:ethyl acetate (2:8) as mobile phase. After completion of reaction, the mixture was diluted with ethyl acetate (20 mL) and water was added. The organic layer was dried over sodium sulfate and solvent was removed under reduced pressure. Crude product purified by tituration with diethyl ether to give 0.011 g of N-(3-((5-fluoro-2-((4-(2-methoxyethoxy)phenyl)amino)pyrimidin-4-yl)amino)phenyl)oxirane-2-carboxamide. 1H NMR: DMSO-d6 (400 MHz): 2.881 (d, 1H, J=4.4), 2.98 (t, 1H), 3.30 (s, 3H), 3.63 (m, 3H), 4.01 (t, 2H, J=4.0), 6.77 (d, 2H, J=9.2), 7.27 (t, 1H, J=8), 7.35 (d, 1H, J=8.4), 7.52 (d, 3H, J=8.8), 7.93 (s, 1H), 8.07 (d, 1H, J=3.2), 8.99 (s, 1H), 9.37 (d, 1H, J=18), 10.19 (s, 1H).
Wird geladen…